Related Experiment Video

Updated: Jul 15, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Alterations of blood glucose homeostasis in critically ill children - hyperglycemia

Ewa Otto-Buczkowska1, Tomasz Dworzecki, Urszula Mazur

  • 1Upper Silesia Mother and Child Health Center, Katowice. em.buczkowski@pro.onet.pl

Pediatric Endocrinology, Diabetes, and Metabolism
|May 12, 2007
PubMed

Insights

Critically ill children often experience hyperglycemia, linked to illness severity, not diagnosis. Strict glycemic control using continuous insulin infusion is feasible and may prevent complications in high-risk pediatric patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Endocrinology
  • Metabolic Disorders

Background:

  • Hyperglycemia is frequently observed in critically ill children.
  • Illness severity, rather than specific diagnoses, is strongly associated with hyperglycemia.
  • Severe hyperglycemia may lead to end-organ dysfunction and complications.

Purpose of the Study:

  • To assess the feasibility and efficacy of strict glycemic control in critically ill children.
  • To investigate the potential of continuous insulin infusion to manage hyperglycemia.
  • To reduce mortality and end-organ dysfunction in high-risk pediatric patients.

Main Methods:

  • Prospective, randomized trial design.
  • Implementation of strict glycemic control protocols.
  • Utilized continuous insulin infusion for glucose management.

Main Results:

  • Continuous insulin infusion demonstrated safe and rapid improvement in intravenous glucose tolerance.
  • Strict glycemic control is a feasible intervention in this patient population.
  • Hyperglycemia is a significant marker of illness severity in pediatric critical care.

Conclusions:

  • Strict glycemic control is warranted and feasible in critically ill children with severe hyperglycemia.
  • Continuous insulin infusion is an effective method for improving glucose tolerance.
  • Further research into strict glycemic control can potentially reduce complications and mortality.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...